Glycoside hydrolase family 11/12, catalytic domain / Glycoside hydrolase family 11, active site 2 / Glycosyl hydrolases family 11 (GH11) active site signature 2. / Glycoside hydrolase family 11, active site 1 / Glycosyl hydrolases family 11 (GH11) active site signature 1. / Glycoside hydrolase family 11 / Glycosyl hydrolases family 11 (GH11) domain / Glycosyl hydrolases family 11 / Glycosyl hydrolases family 11 (GH11) domain profile. / Glycoside hydrolase family 11/12 ...Glycoside hydrolase family 11/12, catalytic domain / Glycoside hydrolase family 11, active site 2 / Glycosyl hydrolases family 11 (GH11) active site signature 2. / Glycoside hydrolase family 11, active site 1 / Glycosyl hydrolases family 11 (GH11) active site signature 1. / Glycoside hydrolase family 11 / Glycosyl hydrolases family 11 (GH11) domain / Glycosyl hydrolases family 11 / Glycosyl hydrolases family 11 (GH11) domain profile. / Glycoside hydrolase family 11/12 / Concanavalin A-like lectin/glucanase domain superfamily / Jelly Rolls / Sandwich / Mainly Beta 類似検索 - ドメイン・相同性
Chem-7V7 / : / Endo-1,4-beta-xylanase A 類似検索 - 構成要素
モノクロメーター: Double-crystal Si(111) / プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray
放射波長
波長: 0.999878 Å / 相対比: 1
反射
解像度: 1.67→51.87 Å / Num. obs: 65282 / % possible obs: 98.9 % / 冗長度: 4.3 % / Biso Wilson estimate: 13.02 Å2 / Rmerge(I) obs: 0.079 / Net I/σ(I): 14.2
反射 シェル
解像度: 1.67→1.73 Å / 冗長度: 4.4 % / Rmerge(I) obs: 0.69 / Mean I/σ(I) obs: 2.1 / CC1/2: 0.69 / % possible all: 99.9
-
解析
ソフトウェア
名称
バージョン
分類
XDS
データ削減
PHASER
2.5.6.
位相決定
Coot
0.8
モデル構築
PHENIX
dev_2463
精密化
PDB_EXTRACT
3.2
データ抽出
精密化
解像度: 1.67→51.87 Å / SU ML: 0.2 / 交差検証法: FREE R-VALUE / σ(F): 1.34 / 位相誤差: 19.7 詳細: Iterative rounds of model building in Coot and refinement in Phenix. Refinement parameters included real and reciprocal space, individual ADPs, Occupanices, Optimization of X-ray to ...詳細: Iterative rounds of model building in Coot and refinement in Phenix. Refinement parameters included real and reciprocal space, individual ADPs, Occupanices, Optimization of X-ray to stereochemical and X-ray to ADP weights. Hydrogens were added automatically and Automatic correction of N/Q/H errors was used. Updated solvent model was used in the penultimate round of refinement. Manual modeling of solvent was conducted before the final round of refinement.